Conference abstract · 7 Mar 2016
Conference abstractPublished 30 Jun 2016
Highly sensitive biomarker detection via stimuli-responsive reagents
University of Washington, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clinical diagnostic tests such as immunoassay have been utilized for patient diagnosis to significantly improve health care and reduce costs by detecting trace amounts of certain proteins in patients for identifying harmful cells and troublesome cellular processes. The mainstream immunoassays utilize antibodies immobilized on solid supports for biomarker recognition and separation, which result in long assay time and compromise assay detection limit. In order to achieve higher assay sensitivity, our group has developed stimuli-responsive affinity reagents to address some of the biomarker separation challenges. The reagents such as antibodies conjugated with stimuli-responsive polymers respond sharply and reversibly to physical or chemical stimuli by changing their conformation and physical-chemical properties, i.e. changing from a hydrophilic state to a more hydrophobic state. Stimuli-responsive reagents can replace the antibodies immobilized at solid supports to overcome the mass transport limitations associated with heterogeneous immunoassays because the biomarker binding occurs in a homogeneous solution where molecular diffusion of the reagents facilitates rapid mass transport equilibration. The conjugates can interface with different diagnostic devices to enable rapid immunoassay by facilitating simple and effective biomarkers (or full sandwich immunocomplexes) separation and detection. Additionally, the rapid assay system is scalable to larger starting volumes, which provides opportunities to concentrate dilute biomarkers, thus improving detection ranges and expanding diagnostic options in immunoassays. In this presentation, I will discuss the utilities of stimuli-responsive affinity reagents for microfluidic immunoassay to enable sensitive detection for prostate specific antigen in human plasma as well as rapid biomarker purification and enrichment for infectious disease such as malaria.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 3 Oct 2016
Towards early stage detection of ovarian cancer via lysophosphatidic acid as a biomarker
Article · 30 Jun 2025
Smart/Stimuli-Responsive Nanoparticles: Precision Drug Delivery for Advanced Therapeutics
Short communication · 30 Jun 2025
Stimuli-Responsive Drug Delivery: Smart Systems for Targeted Therapeutics
Article · 29 Apr 2025
Stimuli-responsive Nanocarriers for On-demand Drug Delivery
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “James J Lai”
